Juvenile hyaline fibromatosis.
Mehmet Mutlu
N
N
Kirdemir
Pakize
P
Nermin
Gögüş
G
D018685:Anesthetics, Inhalation / Q000627:therapeutic use; D018686:Anesthetics, Intravenous / Q000627:therapeutic use; D002648:Child; D005350:Fibroma / Q000150:complications* / Q000235:genetics; D005808:Genes, Recessive; D005885:Gingival Hyperplasia / Q000150:complications; D006258:Head and Neck Neoplasms / Q000150:complications; D006801:Humans; D007442:Intubation, Intratracheal / Q000379:methods; D007592:Joint Diseases / Q000150:complications* / Q000601:surgery*; D007719:Knee Joint / Q000601:surgery; D008297:Male; D008738:Methyl Ethers / Q000627:therapeutic use; D008874:Midazolam / Q000627:therapeutic use; D003473:Neuromuscular Nondepolarizing Agents / Q000627:therapeutic use; D015742:Propofol / Q000627:therapeutic use; D035583:Rare Diseases; D000077149:Sevoflurane; D014421:Turkey; D014673:Vecuronium Bromide / Q000627:therapeutic use
D018685:Anesthetics, Inhalation; D018686:Anesthetics, Intravenous; D008738:Methyl Ethers; D003473:Neuromuscular Nondepolarizing Agents; D000077149:Sevoflurane; D014673:Vecuronium Bromide; D008874:Midazolam; D015742:Propofol